At Oraderm, we are driven with a purpose. To enhance the health and well-being of all patients by providing affordable access to Dermatological medications that improve the quality of their lives because “Clear Skin Matters”.
Building a presence in dermatology, Oraderm’s foundation began as a specialist focused company with a shared ownership between Arrotex and Douglas Pharmaceuticals New Zealand. Oraderm, now fully owned by Arrotex Pharmaceuticals – a division of DBG Health, is now broadening beyond its specialty focus to deliver dermatologist solutions that deliver benefits to a wider range of patients.
Committed to building a future for all Australians, Oraderm continues to bring affordable and innovative new medicines for the treatment of a wide range of skin diseases in Australia. Oraderm is committed to building partnerships and working together with Healthcare Professionals and Patient Organizations to uncover unmet patients’ needs. Paving the road to affordable healthcare and achieving best patient outcomes.